We have been advocating that the diversity in genomics research is an issue since Mawi DNA’s inception in 2014. Interestingly, in late 2018 and now 2019 several publications came out to describe this issue in greater details. Unfortunately, such gap of genetic data hinders progress in understanding the global picture of human health and in particular personalized and precision medicine including the pharmacogenomics of how our bodies react to different drugs.
Spit and/or saliva collection might have been an acceptable alternative to getting gDNA from blood sample. But now it is becoming obvious that its use has many limitations:
iSWAB checks all of these requirements and more, making it a true universal sample collection technology!
Swabs are known to be a universal sample collection tool but lacked gDNA quantity and quality. Using it with iSWAB resolves this issue and thus making accessibility of samples from across the globe regardless of age, medical condition or level of education. iSWAB is bringing diversity back to genetic and multi-OMICS research.
Article Sources:
https://www.statnews.com/2019/03/06/lack-diversity-hinders-genetic-studies/
https://www.sciencedaily.com/releases/2019/06/190619142605.htm
https://academic.oup.com/bioscience/article/69/8/684/5522596
https://blogs.scientificamerican.com/voices/we-need-more-diversity-in-our-genomic-databases/
Candida Data Using iSWAB In Response to New Infectious Diseases...
A deadly fungal infection, Candida Auris, is becoming a serious threat. This drug-resistant strain is deadly for those with weakened immune systems and is spreading at an alarming rate. The READ MORE
Top Reasons to Ditch Your Current VTM. Upgrade your Viral…...
Mawi DNA has developed iSWAB-RC-EL, an FDA approved sample collection device for transport and storage of samples suspected of containing an infectious disease*. Why iSWAB-RC-EL is the superior op...
READ MOREMawi DNA Announces Dr. Bouzyk as New Board Member!...
It is with great delight and excitement that we announce that Dr. READ MORE